๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Irradiation with and without Razoxane in the Treatment of Incompletely Resected or Inoperable Recurrent Rectal Cancer

โœ Scribed by Walter Rhomberg; Josef Hammer; Felix Sedlmayer; Helmut Eiter; Dieter Seewald; Barbara Schneider


Publisher
Springer
Year
2007
Tongue
German
Weight
232 KB
Volume
183
Category
Article
ISSN
0179-7158

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Radical cystectomy with or without plann
โœ Barzell, Winston ;Whitmore, Willet F. ๐Ÿ“‚ Article ๐Ÿ“… 1978 ๐Ÿ› Springer ๐ŸŒ English โš– 227 KB

A retrospective analysis of 342 patients with carcinoma of the bladder treated by radical cystectomy at Memorial Sloan Kettering Cancer Center with or without planned preoperative irradiation revealed that preoperative irradiation significantly improved survival of patients with deeply infiltrating

Comparison of the mortality, morbidity a
โœ Mr P. Gillen; A. L. G. Peel ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 375 KB ๐Ÿ‘ 2 views

Abstract One hundred patients with rectal cancer treated by one surgeon over a 7 year period are reviewed. Fifty-five patients were treated by stapled anterior resection (SAR) and 45 by abdominoperineal resection (APR). Dukes' classification, degree of differentiation and local spread were similar i

Cisplatin, epirubicin, and vindesine wit
โœ Giovanni P. Ianniello; Giuseppe De Cataldis; Pasquale Comella; Michele Della Vit ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 668 KB

## BACKGROUND. Lonidamine (LND) is an indazol-carboxylic acid derivative that selectively inhibits the energy metabolism of neoplastic cells, and increases the permeability of cell membranes. In vitro studies have demonstrated that LND can potentiate the oncolytic activity of cytotoxic drugs and i

Gemcitabine in combination with 5-fluoro
โœ Helmut Oettle; Hanno Riess ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 102 KB ๐Ÿ‘ 1 views

Pancreatic cancer is one of the most frequently reported gastrointestinal tumors and has been reported to have a 5-year survival rate of < 5%. It is most commonly diagnosed at an advanced stage and until recently, the most frequently administered treatment for patients with advanced disease has been